VSM MedTech Ltd. (VSM.TO) Buy, Sell or Hold

VSM MedTech Ltd. (VSM.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

0 watching

WATCH

Ranks in the bottom 4% of the database. New management. More conservative accounting practices. Sales growth is down. Very good technology. Expected it will be June/04 before you begin to see any traction.

PAST TOP PICK

(A past top pick Nov 17/03. Up 14.6%.) Great new management team. They've cleaned up their accounting. Dropping because of one seller.

DON'T BUY

Revenues dropped and they lost some contracts. Have a large debt load. Too expensive.

WATCH

With the drop in the price, can't see a huge valuation risk. Bringing in a new CEO is good. The bigger risk is if there is a good market for their devices. Very speculative.

WAIT

Over aggressive sales practices resulted in $150 million market cap reduction by the market. A new change in President and is now working its way back. Very expensive based on their new revenue recognition policy. Would be viable at the $2/2.50 range.

DON'T BUY

As a conservative investor, not his type of investment. Sloppy accounting practices give huge credibility issues. Change of CEO is probably good.

BUY

Have a real technology. The stock dropped, because they had orders which were booked as revenue and which did not come through. Somewhat speculative because of dependency on sales.

PAST TOP PICK

(A top pick Oct 10/03. down 7.55/3.95%.) Lost a sale through a customer’s bad financing. Still likes.

TOP PICK

Because of a customers financing difficulty, took a big drop. They have been adding to their positions at the lower price. Their technology is infallible. Should be a very successful story.

TOP PICK

Great product with strong demand. Had to restate 2nd quarter results because of a deal falling through. Being oversold. Great price.

WAIT

The chart on this stock gives a little bit of concern. It looks like a double top. Tried to break through $7.80 twice. Wait for it to break through. Currently looking at developing an MRI hybrid for imaging of the brain in utro(?) foetuses.

TOP PICK

Have just made a deal with GE for distribution in China. 120% earnings growth.

BUY

A very exciting company. Prices dropped, so a good buying opportunity.

TOP PICK

Have a new product. Being recognized by insurance companies. Expects a 13% upside.

BUY

Buy for the long term. Very attractive valuation.

Showing 31 to 45 of 58 entries

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

VSM MedTech Ltd. (VSM.TO)